Literature DB >> 22018061

Melanoma reporting to central cancer registries by US dermatologists: an analysis of the persistent knowledge and practice gap.

Todd V Cartee1, Seema P Kini, Suephy C Chen.   

Abstract

BACKGROUND: Every state requires diagnosing physicians to report new cases of melanoma to its central cancer registry. Previous regional studies and anecdotal experience suggest that few dermatologists are cognizant of this obligation. This oversight could result in a large number of unreported melanomas annually and, in turn, US melanoma statistics that markedly underestimate the true incidence of the disease.
OBJECTIVE: We sought to quantify the percentage of dermatologists who are unaware of melanoma reporting requirements (the knowledge gap) and who are not reporting melanoma diagnoses (the practice gap). We also sought to delineate factors predictive of reporting knowledge and behavior.
METHODS: A survey was administered to attendees of the Cutaneous Oncology Symposium at the 2010 American Academy of Dermatology annual meeting.
RESULTS: In all, 104 of 419 eligible attendees completed surveys (response rate 26%). Fifty percent of respondents do not believe they are required to report melanomas and 56% do not actively report their diagnoses to a registry. Practice duration of less than 10 years was significantly associated with both a knowledge gap (P = .047) and practice gap (P = .056). Similarly, dermatologists who diagnosed fewer than 10 melanomas per year were more likely to possess a knowledge gap (P = .096) and a practice gap (P = .087) than those who diagnosed more than 10. LIMITATIONS: Limitations include small sample size and low response rate.
CONCLUSION: A majority of dermatologists are not reporting melanomas they diagnose to a cancer registry, and half of those surveyed were not aware that diagnosing physicians are required to report melanoma.
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22018061     DOI: 10.1016/j.jaad.2011.05.032

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  13 in total

1.  Underreporting of Melanoma in Arizona and Strategies for Increasing Reporting: A Public Health Partnership Approach.

Authors:  Robin B Harris; Stephanie M Koch; Chris Newton; Nancy G Silvis; Clara Curiel-Lewandroski; Joseph Giancola; Paul Sagerman; Steven Alder; Georgia Yee; Timothy J Flood
Journal:  Public Health Rep       Date:  2015 Nov-Dec       Impact factor: 2.792

2.  Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure.

Authors:  Thomas B Richards; Christopher J Johnson; Zaria Tatalovich; Myles Cockburn; Melody J Eide; Kevin A Henry; Sue-Min Lai; Sai S Cherala; Youjie Huang; Umed A Ajani
Journal:  J Am Acad Dermatol       Date:  2011-11       Impact factor: 11.527

3.  Predictors of neighborhood risk for late-stage melanoma: addressing disparities through spatial analysis and area-based measures.

Authors:  Shasa Hu; Recinda Sherman; Kristopher Arheart; Robert S Kirsner
Journal:  J Invest Dermatol       Date:  2013-11-07       Impact factor: 8.551

4.  Follow-up of a Large Prospective Cohort in the United States Using Linkage With Multiple State Cancer Registries.

Authors:  Eric J Jacobs; Peter J Briggs; Anusila Deka; Christina C Newton; Kevin C Ward; Betsy A Kohler; Susan M Gapstur; Alpa V Patel
Journal:  Am J Epidemiol       Date:  2017-10-01       Impact factor: 4.897

5.  Melanoma burden and recent trends among non-Hispanic whites aged 15-49years, United States.

Authors:  Meg Watson; Alan C Geller; Margaret A Tucker; Gery P Guy; Martin A Weinstock
Journal:  Prev Med       Date:  2016-08-24       Impact factor: 4.018

Review 6.  Screening and prevention measures for melanoma: is there a survival advantage?

Authors:  Clara Curiel-Lewandrowski; Suephy C Chen; Susan M Swetter
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

Review 7.  Melanoma treatment costs: a systematic review of the literature, 1990-2011.

Authors:  Gery P Guy; Donatus U Ekwueme; Florence K Tangka; Lisa C Richardson
Journal:  Am J Prev Med       Date:  2012-11       Impact factor: 5.043

8.  Characteristics, rates, and trends of melanoma incidence among Hispanics in the USA.

Authors:  Erin Garnett; Julie Townsend; Brooke Steele; Meg Watson
Journal:  Cancer Causes Control       Date:  2016-03-28       Impact factor: 2.506

9.  Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression.

Authors:  Jong Y Park; Ernest K Amankwah; Gabriella M Anic; Hui-Yi Lin; Brooke Walls; Hyun Park; Kevin Krebs; Melissa Madden; Kristen Maddox; Suroosh Marzban; Shenying Fang; Wei Chen; Jeffrey E Lee; Qingyi Wei; Christopher I Amos; Jane L Messina; Vernon K Sondak; Thomas A Sellers; Kathleen M Egan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-05       Impact factor: 4.254

10.  Caffeic acid phenethyl ester suppresses melanoma tumor growth by inhibiting PI3K/AKT/XIAP pathway.

Authors:  Kartick C Pramanik; Shashi K Kudugunti; Neel M Fofaria; Majid Y Moridani; Sanjay K Srivastava
Journal:  Carcinogenesis       Date:  2013-05-02       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.